Northrop Grumman is currently trading below its 5-year average valuation despite a strong growth outlook. The company reported a record backlog of $105 billion, driven by multi-year missile contracts and investments in capacity that are expected to boost profit margins. After strong Q2 earnings, the company raised its guidance, with expected EBITDA reaching $6.6 billion in 2026 and over $7 billion in 2027. While valuation risks and sector-wide market corrections remain concerns, the company's fundamentals appear solid, making it a potentially attractive investment opportunity.
Andrew Sather, co-host of The Investing for Beginners Podcast, chooses not to invest in SpaceX at its IPO due to uncertainty and a personal rule against buying IPOs. He suggests waiting for price stabilization before considering investment. Meanwhile...
In June, President Donald Trump disclosed more than 1,000 financial transactions involving stocks, bonds, and ETFs, indicating a broad reshuffling of his investment portfolio. His transactions ranged between $78.1 million and $263.1 million, with pur...
